SAFETY AND EFFICACY OF RECOMBINATE IN PREVIOUSLY UNTREATED HEMOPHILIA A PATIENTS

被引：0
|
作者：
BRAY, G
GORDON, EM
LIUMARUYA, S
COURTER, S
GOMPERTS, E
机构：
[1] CHILDRENS HOSP,NATL MED CTR,WASHINGTON,DC 20010
[2] CHILDRENS HOSP,LOS ANGELES,CA 90027
[3] BAXTER HYLAND DIV,GLENDALE,CA
来源：
TRANSFUSION | 1992年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [1] A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
    BRAY, GL
    GOMPERTS, ED
    COURTER, S
    GRUPPO, R
    GORDON, EM
    MANCOJOHNSON, M
    SHAPIRO, A
    SCHEIBEL, E
    WHITE, G
    LEE, M
    GORDON, M
    BERTALONE, S
    LIPTON, R
    HILGARTNER, M
    ARKIN, S
    GILL, J
    KIM, H
    SHURIN, S
    SANTIAGOBORRERO, P
    ARKEL, YS
    KULKARNI, R
    GREENWOOD, MF
    RITCHEY, AK
    WERNER, E
    HAIRE, WD
    KISKER, T
    NEUFELD, E
    EWENSTEIN, B
    DEBIASI, R
    LAURIAN, Y
    KREUZ, W
    RODEGHIERO, F
    INGERSLEV, J
    GAZENGEL, C
    DIMICHELE, D
    COOPER, H
    BLOOD, 1994, 83 (09) : 2428 - 2435
  • [2] EFFICACY AND SAFETY OF PROPHYLAXIS IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A IN IRAN
    Karimi, M.
    Eshghi, P.
    Haghpanah, S.
    Zahedi, Z.
    Habibpanah, B.
    HAEMATOLOGICA, 2015, 100 : 409 - 409
  • [3] SAFETY, EFFICACY AND INHIBITOR RISK OF RECOMBINANT FACTOR-VIII (RECOMBINATE(R)) IN A COHORT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH SEVERE HEMOPHILIA-A
    BRAY, GL
    COURTER, S
    LYNES, M
    LEE, M
    GOMPERTS, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1205 - 1205
  • [4] Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
    Taki, Masashi
    Fukutake, Katsuyuki
    Matsushita, Tadashi
    Nogami, Keiji
    Shima, Midori
    Yoshioka, Akira
    Takamatsu, Junki
    Arai, Morio
    Takagi, Hiroshi
    Uchikawa, Haruhiko
    Engl, Werner
    Shirahata, Akira
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 70 - 78
  • [5] Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
    Masashi Taki
    Katsuyuki Fukutake
    Tadashi Matsushita
    Keiji Nogami
    Midori Shima
    Akira Yoshioka
    Junki Takamatsu
    Morio Arai
    Hiroshi Takagi
    Haruhiko Uchikawa
    Werner Engl
    Akira Shirahata
    International Journal of Hematology, 2019, 109 : 70 - 78
  • [6] CLINICAL-STUDIES OF RECOMBINANT FACTOR-VIII (RECOMBINATE) IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA-A
    BRAY, GL
    LEE, ML
    COURTER, S
    GOMPERTS, E
    BLOOD, 1993, 82 (10) : A446 - A446
  • [7] A safety and efficacy evaluation of rFIX in previously untreated patients (PUPS) with severe and moderately severe hemophilia B
    Shapiro, A
    Pasi, KJ
    Courter, S
    Tubridy, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS212 - PS212
  • [8] Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B
    Shapiro, AD
    Ragni, MV
    Lusher, JM
    Culbert, S
    Koerper, MA
    Bergman, GE
    Hannan, MM
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (01) : 30 - 35
  • [9] Guardian™ 4: safety and efficacy of turoctocog alfa in prevention and treatment of bleeds in previously untreated patients with hemophilia A
    Ozelo, M.
    Wu, R.
    Belhani, M.
    Lebedev, V.
    Yaish, H.
    Korsholm, L.
    Matytsina, I.
    Matsushita, T.
    HAEMOPHILIA, 2018, 24 : 101 - 102
  • [10] Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
    Masashi Taki
    Katsuyuki Fukutake
    Tadashi Matsushita
    Keiji Nogami
    Midori Shima
    Akira Yoshioka
    Junki Takamatsu
    Morio Arai
    Hiroshi Takagi
    Haruhiko Uchikawa
    Werner Engl
    Akira Shirahata
    International Journal of Hematology, 2019, 109 : 241 - 241
12345